Signum Nutralogix Information

Signum Nutralogix, a spin out of Signum Biosciences, is a private biotech company founded in 2012. We are dedicated to developing innovative dietary supplements targeted towards enhancing health. To accomplish this, we are exploiting research breakthroughs at from technologies developed by Dr. Jeffry Stock at Princeton University which are targeted toward cellular signal transduction pathways, the process by which cells interpret and respond to the external cues that shape their activity. Central to this vision is the belief that modulating this specific biochemical target will yield innovative consumer healthcare products. EHT™ was derived using a new technology platform developed by researchers at Princeton University. We have developed our first dietary supplement using this patented screening process. Also we have broad composition and methods intellectual property protection on the product. EHT® is a unique mixture of bioactive molecules identified using our patented screening technology. It is a naturally occurring, proprietary extract found in coffee. It is one of the key ingredients in Nerium EHT® Age-Defying Supplement, Mind Enhancement™ Formula, helping to improve brain health and promote balanced brain chemistry. EHT® works by helping neurons, the “wiring” in the brain, maintain an optimal functional state by protecting PP2A. Ensuring that PP2A is in a balanced state provides neuroprotection. Nutralogix’s goal is to become the leader of brain health market segment. Each element of the Company’s strategy is designed to enhance the Company brand, build the customer base, and engender loyalty and repeat business among its customers.